Melanomás betegek stádium szerinti megoszlása egy hazai centrumban

Translated title of the contribution: Stage distribution of malignant melanomas in a Hungarian centre

Veronika Tóth, Beáta Somlai, Judit Hársing, Zsófia Hatvani, Sarolta Kárpáti

Research output: Contribution to journalArticle

1 Citation (Scopus)


Introduction: Survival of patients with malignant melanoma primarily depends on tumor stage. Hungarian National Cancer Registry does not specify tumors according to TNM stages. Aim: The authors aimed to survey the stage distribution of melanomas at the Department of Dermatology, Dermatooncology and Venerology, Semmelweis University. Method: 1160 patients (558 males and 602 females, aged 60.5±16 and 57±17 years, respectively) diagnosed with cutaneous melanoma between 2004-2009 were included. Results: In comparison with international studies, the case distribution was favorable in stages IA and IV, i.e. the proportion of early melanomas was relatively high (IA: 43.8%), while the incidence in stage IV was low (0.4%). In stages IB-IIA the incidence was significantly lower, while in IIC, IIIA, IIIB it was higher as compared to published data from Western-Europe, Australia and the United States. Conclusions: The study underlines the necessity of prevention and awareness campaigns that may result in increase of early diagnosis of melanomas.

Translated title of the contributionStage distribution of malignant melanomas in a Hungarian centre
Original languageHungarian
Pages (from-to)969-976
Number of pages8
JournalOrvosi hetilap
Issue number25
Publication statusPublished - Jun 1 2013

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Stage distribution of malignant melanomas in a Hungarian centre'. Together they form a unique fingerprint.

  • Cite this